Ilya Rachman is Chief Executive Officer, Chief Scientific Officer and Chairman of Immix Biopharma, Inc. (IMMX). The company reported total compensation of $1,352,854 for fiscal year 2025.
| Salary | $475,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $0 |
| Option awards | $592,854 |
| Non-equity incentive plan | $285,000 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $0 |
| Total | $1,352,854 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Immix Biopharma, Inc. filed April 6, 2026, accession 0001493152-26-015320.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Gabriel Morris | Chief Financial Officer, President and Director | $1,352,854 |
| Ilya Rachman this page | Chief Executive Officer, Chief Scientific Officer and Chairman | $1,352,854 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Immix Biopharma, Inc. compensation brief.
Ilya Rachman's compensation sits inside Immix Biopharma, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.